Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Checkpoint Therapeutics I...

    NASDAQ: CKPT · Real-Time Price · USD
    4.26
    0.00 (0.00%)
    At close: May 29, 2025, 3:59 PM

    Checkpoint Therapeutics Statistics

    Share Statistics

    Checkpoint Therapeutics has 86.32M shares outstanding. The number of shares has increased by 33.15% in one year.

    Shares Outstanding

    n/a
    		 86.32M

    Shares Change (YoY)

    n/a
    		 33.15%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 25.62%

    Shares Floating

    n/a
    		 66.45M

    Failed to Deliver (FTD) Shares

    n/a
    		 4

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 2.96M, so 3.4% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 2.96M

    Short % of Shares Out

    n/a
    		 3.4%

    Short % of Float

    n/a
    		 3.68%

    Short Ratio (days to cover)

    n/a
    		 3.72

    Valuation Ratios

    The PE ratio is -2.26 and the forward PE ratio is 3.77. Checkpoint Therapeutics's PEG ratio is 0.05.

    PE Ratio

    n/a
    		 -2.26

    Forward PE

    n/a
    		 3.77

    PS Ratio

    n/a
    		 3096.54

    Forward PS

    n/a
    		 0.8

    PB Ratio

    n/a
    		 -10.06

    P/FCF Ratio

    n/a
    		 -4.08

    PEG Ratio

    n/a
    		 0.05
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Checkpoint Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 0.37, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 0.37

    Quick Ratio

    n/a
    		 0.37

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $1,708.33

    Profits Per Employee

    n/a
    		 $-2,343,333.33

    Employee Count

    n/a
    		 24

    Asset Turnover

    n/a
    		 0.01

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 125.4% in the last 52 weeks. The beta is 1.14, so Checkpoint Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.14

    52-Week Price Change

    n/a
    		 125.4%

    50-Day Moving Average

    n/a
    		 4.09

    200-Day Moving Average

    n/a
    		 3.33

    Relative Strength Index (RSI)

    n/a
    		 79.34

    Average Volume (20 Days)

    n/a
    		 3,078,214

    Income Statement

    In the last 12 months, Checkpoint Therapeutics had revenue of 41K and earned -56.24M in profits. Earnings per share was -1.42.

    Revenue

    n/a
    		 41K

    Gross Profit

    n/a
    		 41K

    Operating Income

    n/a
    		 -56.17M

    Net Income

    n/a
    		 -56.24M

    EBITDA

    n/a
    		 -56.17M

    EBIT

    n/a
    		 -56.17M

    Earnings Per Share (EPS)

    n/a
    		 -1.42
    Full Income Statement

    Balance Sheet

    The company has 6.6M in cash and 0 in debt, giving a net cash position of 6.6M.

    Cash & Cash Equivalents

    n/a
    		 6.6M

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 -370.57M

    Total Assets

    n/a
    		 34.16M

    Working Capital

    n/a
    		 16.3M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -31.1M and capital expenditures 0, giving a free cash flow of -31.1M.

    Operating Cash Flow

    n/a
    		 -31.1M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -31.1M

    FCF Per Share

    n/a
    		 -0.78
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of -137009.76% and -137170.73%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 -137009.76%

    Pretax Margin

    n/a
    		 -137170.73%

    Profit Margin

    n/a
    		 -137170.73%

    EBITDA Margin

    n/a
    		 -137009.76%

    EBIT Margin

    n/a
    		 -137009.76%

    FCF Margin

    n/a
    		 -75856.1%

    Dividends & Yields

    CKPT does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for CKPT is $4.1, which is -3.8% lower than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $4.1

    Price Target Difference

    n/a
    		 -3.8%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 3
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Dec 6, 2022. It was a backward split with a ratio of 1:10.

    Last Split Date

    n/a
    		 Dec 6, 2022

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:10

    Scores

    Altman Z-Score

    n/a
    		 -8.25

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist